Cabio Biotech (Wuhan) Co., Ltd. Stock Price

Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally. The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (ß)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides. Its products are used in human nutrition, including early life nutrition and dietary supplements; animal nutrition, such as economic animal and pet nutrition; personal care and cosmetics; and synthetic biology applications. The company also engages in the production of food additives and other food products; consulting services in bioengineering, environmental protection, healthcare, and food technologies; research, development, and sale of biological feed and feed additives; food wholesale; technology development; and venture capital activities. Cabio Biotech (Wuhan) Co., Ltd. was founded in 1999 and is based in Wuhan, the People’s Republic of China.